Sugar, sex, and TGF-β in diabetic nephropathy
- PMID: 22835457
- PMCID: PMC3442601
- DOI: 10.1016/j.semnephrol.2012.04.005
Sugar, sex, and TGF-β in diabetic nephropathy
Abstract
TGF-β is well known to play a critical role in diabetic kidney disease, and ongoing clinical studies are testing the potential therapeutic promise of inhibiting TGF-β production and action. An aspect of TGF-β action that has not received much attention is its potential role in explaining sex-related proclivity for kidney disease. In this review, we discuss recent studies linking TGF-β signaling to sex-related effects in diabetic kidney disease and suggest targets for future studies.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement: none.
Figures


References
-
- Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev. 2004;25:971–1010. - PubMed
-
- Centers for Disease Control and Prevention. Incidence of end-stage renal disease among persons with diabetes—United States, 1990 –2002. MMWR Morb Mortal Wkly Rep. 2005;54:1097–100. - PubMed
-
- Reddy AS. Diabetic nephropathy: theory & practice. East Hanover, NJ: College Book Publishers, LLC; 2004. p. 563.
-
- Choi KH, Kang SW, Lee HY, Han DS. The effects of high glucose concentration on angiotensin II- or transforming growth factor-beta-induced DNA synthesis, hypertrophy and collagen synthesis in cultured rat mesangial cells. Yonsei Med J. 1996;37:302–11. - PubMed
-
- Hayden MR, Whaley-Connell A, Sowers JR. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte. Am J Nephrol. 2005;25:553–69. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical